John C. Ansel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
John C. Ansel has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Cheryl A. Armstrong
3 shared publicationsDirk‐Henner Kalden
Ludwig Boltzmann Institute for Cellbiology and Immunobiology of the Skin, Department of Dermatology, University of Münster, Germany
2 shared publicationsMechthild Hartmeyer
Ludwig Boltzmann Institute for Cellbiology and Immunobiology of the Skin, Department of Dermatology, University of Münster, Germany
2 shared publicationsNigel W. Bunnett
2 shared publicationsS. Wright Caughman
2 shared publicationsThomas A. Luger
Ludwig Boltzmann Institute for Cellbiology and Immunobiology of the Skin, Department of Dermatology, University of Münster, Germany
2 shared publications
Latest Publications
- 1 December 2000
- Published by Elsevier in Journal of Investigative Dermatology Symposium Proceedings
- Vol. 5 (1) , 74-78
Neural Regulation of Endothelial Cell-Mediated Inflammation
- 1 December 2000
- Published by Elsevier in Journal of Investigative Dermatology Symposium Proceedings
- Vol. 5 (1) , 74-78
Neural Regulation of Endothelial Cell-Mediated Inflammation
- 1 February 2000
- Published by Wiley in Experimental Dermatology
- Vol. 9 (1) , 42-52
Substance P induction of murine keratinocyte PAM 212 interleukin 1 production is mediated by the neurokinin 2 receptor (NK‐2R)
The neurological system plays an important role in modulating some inflammatory skin diseases. Neuro‐cutaneous interactions may be mediated by the release of neuropeptides such as substance P (SP) which activate immunocompetent cells in the skin by binding to high affinity neurokinin receptors (NKR). Since epidermal keratinocytes produce a variety of cytokines and are intimately associated with cutaneous sensory fibers, we tested the ability of these cells to participate in the cutaneous neuroimmune system by the secretion of potent cytokines such as interleukin 1 (IL‐1) in response to released SP. RT‐PCR studies demonstrated that cultured PAM 212 murine keratinocytes expressed mRNA for NK‐2R but not NK‐1R. Correspondingly, the addition of SP to these cells resulted in a rapid increase in intracellular Ca2+ levels that could be specifically blocked by an NK‐2R antagonist. NK‐2R was also shown in normal mouse epidermis by immunohistochemistry. SP augmented the expression of PAM 212 keratinocyte IL‐1α mRNA in a dose and time dependent manner and this induction was inhibited by an NK‐2R antagonist. Secretion of bioactive IL‐1α by the PAM 212 keratinocytes was likewise stimulated by SP in a dose dependent manner. These data support the hypothesis that SP released from cutaneous sensory nerves contributes to neuroimmune inflammatory responses in the skin by modulating the expression and release of cytokines from epidermal keratinocytes.
- 1 February 2000
- Published by Wiley in Experimental Dermatology
- Vol. 9 (1) , 42-52
Substance P induction of murine keratinocyte PAM 212 interleukin 1 production is mediated by the neurokinin 2 receptor (NK‐2R)
The neurological system plays an important role in modulating some inflammatory skin diseases. Neuro‐cutaneous interactions may be mediated by the release of neuropeptides such as substance P (SP) which activate immunocompetent cells in the skin by binding to high affinity neurokinin receptors (NKR). Since epidermal keratinocytes produce a variety of cytokines and are intimately associated with cutaneous sensory fibers, we tested the ability of these cells to participate in the cutaneous neuroimmune system by the secretion of potent cytokines such as interleukin 1 (IL‐1) in response to released SP. RT‐PCR studies demonstrated that cultured PAM 212 murine keratinocytes expressed mRNA for NK‐2R but not NK‐1R. Correspondingly, the addition of SP to these cells resulted in a rapid increase in intracellular Ca2+ levels that could be specifically blocked by an NK‐2R antagonist. NK‐2R was also shown in normal mouse epidermis by immunohistochemistry. SP augmented the expression of PAM 212 keratinocyte IL‐1α mRNA in a dose and time dependent manner and this induction was inhibited by an NK‐2R antagonist. Secretion of bioactive IL‐1α by the PAM 212 keratinocytes was likewise stimulated by SP in a dose dependent manner. These data support the hypothesis that SP released from cutaneous sensory nerves contributes to neuroimmune inflammatory responses in the skin by modulating the expression and release of cytokines from epidermal keratinocytes.
- 1 October 1999
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 885 (1) , 444-447
Expression of Proopiomelanocortin Peptides and Prohormone Convertases by Human Dermal Microvascular Endothelial Cells
- 1 October 1999
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 885 (1) , 444-447
Expression of Proopiomelanocortin Peptides and Prohormone Convertases by Human Dermal Microvascular Endothelial Cells
- 1 October 1999
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 885 (1) , 239-253
Expression of Functional Melanocortin Receptors and Proopiomelanocortin Peptides by Human Dermal Microvascular Endothelial Cells
Human dermal microvascular endothelial cells (HDMEC) are capable of mediating leukocyte‐endothelial interactions by the expression of cellular adhesion molecules and the release of proinflammatory cytokines and chemokines during cutaneous inflammation. Recent studies support the important role for proopiomelanocortin (POMC) peptides, such as α‐melanocyte stimulating hormone (α‐MSH), as immunomodulators in the cutaneous immune system. The purpose of the studies described here was to determine whether HDMEC serves as both target and source for POMC peptides. RT‐PCR and Northern blot studies demonstrated the constitutive expression of mRNA for the adrenocorticotropin (ACTH) and α‐MSH‐specific melanocortin receptor 1 (MC‐1R) in HDMEC, and the microvascular endothelial cell line HMEC‐1 that could be upregulated by stimulation with IL‐1β and α‐MSH. HDMEC responded to stimulation by α‐MSH with a dose‐ and time‐dependent synthesis and release of the CXC chemokines, IL‐8 and GROα. Likewise, α‐MSH augmented HDMEC chemokine release induced by TNF or IL‐1. HDMEC were found to constitutively express POMC and prohormone convertase 1 (PC‐1); the latter being required to generate ACTH from the POMC prohormone. POMC and PC‐1 mRNA expression are increased as a result of stimulation with UVB and UVA1 radiation, IL‐1, and α‐MSH. In addition, UV‐radiation is capable of inducing the release of HDMEC, ACTH, and α‐MSH in a time‐ and dose‐dependent fashion. Thus, these data provide evidence that HDMEC are capable of expressing functional MC‐1R, POMC, and PC‐1 mRNA; and of releasing POMC peptides with UV light, IL‐1, and α‐MSH as regulatory factors. The expression and regulation of these peptides may be of importance, not only for the autocrine or paracrine regulation of physiologic functions of dermal endothelial cells, but also for the regulation of certain microvascular‐mediated cutaneous or systemic inflammatory responses.
- 1 October 1999
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 885 (1) , 239-253
Expression of Functional Melanocortin Receptors and Proopiomelanocortin Peptides by Human Dermal Microvascular Endothelial Cells
Human dermal microvascular endothelial cells (HDMEC) are capable of mediating leukocyte‐endothelial interactions by the expression of cellular adhesion molecules and the release of proinflammatory cytokines and chemokines during cutaneous inflammation. Recent studies support the important role for proopiomelanocortin (POMC) peptides, such as α‐melanocyte stimulating hormone (α‐MSH), as immunomodulators in the cutaneous immune system. The purpose of the studies described here was to determine whether HDMEC serves as both target and source for POMC peptides. RT‐PCR and Northern blot studies demonstrated the constitutive expression of mRNA for the adrenocorticotropin (ACTH) and α‐MSH‐specific melanocortin receptor 1 (MC‐1R) in HDMEC, and the microvascular endothelial cell line HMEC‐1 that could be upregulated by stimulation with IL‐1β and α‐MSH. HDMEC responded to stimulation by α‐MSH with a dose‐ and time‐dependent synthesis and release of the CXC chemokines, IL‐8 and GROα. Likewise, α‐MSH augmented HDMEC chemokine release induced by TNF or IL‐1. HDMEC were found to constitutively express POMC and prohormone convertase 1 (PC‐1); the latter being required to generate ACTH from the POMC prohormone. POMC and PC‐1 mRNA expression are increased as a result of stimulation with UVB and UVA1 radiation, IL‐1, and α‐MSH. In addition, UV‐radiation is capable of inducing the release of HDMEC, ACTH, and α‐MSH in a time‐ and dose‐dependent fashion. Thus, these data provide evidence that HDMEC are capable of expressing functional MC‐1R, POMC, and PC‐1 mRNA; and of releasing POMC peptides with UV light, IL‐1, and α‐MSH as regulatory factors. The expression and regulation of these peptides may be of importance, not only for the autocrine or paracrine regulation of physiologic functions of dermal endothelial cells, but also for the regulation of certain microvascular‐mediated cutaneous or systemic inflammatory responses.
- Open Access
- 1 February 1999
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 162 (3) , 1656-1661
VCAM-1 Expression on Human Dermal Microvascular Endothelial Cells Is Directly and Specifically Up-Regulated by Substance P
Sensory nerves in skin are capable of releasing multiple neuropeptides, which modulate inflammatory responses by activating specific cutaneous target cells. Extravasation of particular subsets of leukocytes depends upon the regulated expression of cellular adhesion molecules such as VCAM-1 on microvascular endothelial cells. We examined the direct effect of cutaneous neuropeptides on the expression and function of human dermal microvascular endothelial cell (HDMEC) VCAM-1. A significant increase in VCAM-1 immunostaining of microvascular endothelium was observed in vivo following capsaicin application to human skin. Multiple cutaneous sensory C-fiber-released neuropeptides were evaluated for their ability to induce VCAM-1 cell surface expression on HDMEC. Only substance P (SP) was found to be capable of inducing HDMEC VCAM-1 expression. This SP-mediated VCAM-1 induction appeared to be a direct effect that did not require the release of other HDMEC-derived soluble factors. Increased HDMEC VCAM-1 mRNA expression was detected 1 h after the addition of SP, with peak mRNA increase at 6–9 h postinduction. FACS studies demonstrated a 6.5-fold increase in endothelial cell surface VCAM-1 expression detectable 16 h after addition of SP, which was specifically blocked by a neurokinin-1 receptor antagonist. Increased VCAM-1 cell surface expression on SP-treated HDMEC resulted in a 4-fold increase in the functional binding of 51Cr-labeled MOLT-4 T cells. These data indicate that SP is capable of directly and specifically up-regulating functional endothelial VCAM-1 expression and thus may play a key role in modulating certain inflammatory responses in the skin.
- 1 February 1999
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 162 (3) , 1656-1661
Open AccessVCAM-1 Expression on Human Dermal Microvascular Endothelial Cells Is Directly and Specifically Up-Regulated by Substance P
Sensory nerves in skin are capable of releasing multiple neuropeptides, which modulate inflammatory responses by activating specific cutaneous target cells. Extravasation of particular subsets of leukocytes depends upon the regulated expression of cellular adhesion molecules such as VCAM-1 on microvascular endothelial cells. We examined the direct effect of cutaneous neuropeptides on the expression and function of human dermal microvascular endothelial cell (HDMEC) VCAM-1. A significant increase in VCAM-1 immunostaining of microvascular endothelium was observed in vivo following capsaicin application to human skin. Multiple cutaneous sensory C-fiber-released neuropeptides were evaluated for their ability to induce VCAM-1 cell surface expression on HDMEC. Only substance P (SP) was found to be capable of inducing HDMEC VCAM-1 expression. This SP-mediated VCAM-1 induction appeared to be a direct effect that did not require the release of other HDMEC-derived soluble factors. Increased HDMEC VCAM-1 mRNA expression was detected 1 h after the addition of SP, with peak mRNA increase at 6–9 h postinduction. FACS studies demonstrated a 6.5-fold increase in endothelial cell surface VCAM-1 expression detectable 16 h after addition of SP, which was specifically blocked by a neurokinin-1 receptor antagonist. Increased VCAM-1 cell surface expression on SP-treated HDMEC resulted in a 4-fold increase in the functional binding of 51Cr-labeled MOLT-4 T cells. These data indicate that SP is capable of directly and specifically up-regulating functional endothelial VCAM-1 expression and thus may play a key role in modulating certain inflammatory responses in the skin.